Dalton Whitepapers
Whitepaper: The Dalton Analytical Advantage
Published June 2026
Whitepaper: Drug Repurposing: A Smart Drug Development Strategy
Published May 2023
Whitepaper: Extractables & Leachables in The Pharma Industry
Published April 2023
Whitepaper: Botanical Drug Development Guidance
Published February 2023
Whitepaper: Precision Medicine
Published January 2023
Whitepaper: Drug Development In Oncology
Published December 2022
Whitepaper: Sub-Visible Particles in Sterile Medicinal Products
Published: November 2022
Whitepaper: Adopting Real World Evidence
Published October 2023
Whitepaper: Nitrosamines: A Review
Published September 2022
Whitepaper: Health Canada's National Strategy for Drugs for Rare Diseases
Published August 2023
Whitepaper: Global Medicial Cannabis Regulations - Top 10 Advancements
Published July 2022
Whitepaper: 11 Tips on Supply Chain Management Post Covid
Published May 2022
Whitepaper: Top 12 Recent Global API Regulatory Developments
Published April 2022
Whitepaper: Top 10 Revisions in the EC Annex 1 (2020): A Harmonization of Global Sterile Filling
Published December 2021
Whitepaper: Top 7 Covid-19 Impacts on Global Regulatory Practices in Biotech Industries
Published November 2021
Whitepaper: Regulatory Roadblocks & Expeditions for Global Clinical Trials
Published October 2021
Whitepaper: Global Expedited Review Programs & Incentives
Published June 2021
Whitepaper: FDA Investigational New Drug Application
Published June 2021
Whitepaper: API & Dosage Form Development
Published May 2021
Whitepaper: FDA Guidelines, for GMP of API
Published May 2021
Whitepaper: Canadian Guidelines for GMP Of API
Published April 2021
Whitepaper: Pharmaceutical Psychedelics
Published March 2021
Whitepaper: Orphan Drugs
Published March 2021
Top 7 Considerations When Conducting Extractable & Leachable Studies
Published February 2021
Whitepaper: Extractables & Leachables
Published January 2021